Dr. Matus Coma: Advancing Therapeutic Strategies in Pancreatic Cancer Research


Dr. Matus Coma is a distinguished scientist from Slovakia, recognized for his impactful contributions to pharmacological research and cancer therapeutics. He will be a featured presenter at the 16th Emirates Pathology, Digital Pathology, Cancer Conference & Exhibition, a premier global forum that brings together leading experts in pathology, oncology, and biomedical research. Dr. Coma currently serves as a Leading Scientist in the Department of Pharmacology, Medical Faculty, Pavol Jozef Safarik University, where his research focuses on improving treatment outcomes through innovative drug-based strategies.

Dr. Coma will present a poster titled “Tigecycline Enhances the Cytotoxic Efficacy of FOLFIRINOX and Gem-Pac in Pancreatic Ductal Adenocarcinoma Cell Models” at the conference. This study explores novel therapeutic combinations aimed at enhancing the effectiveness of standard chemotherapy regimens for pancreatic ductal adenocarcinoma—one of the most aggressive and treatment-resistant malignancies. His work reflects the scientific depth and translational relevance showcased at the 16th EPUCG Conference & Exhibition.

Dr. Coma completed his PhD at Pavol Jozef Safarik University and has since built a strong academic and research profile. He has authored over 25 scientific publications in high-impact journals, with his work cited more than 300 times, and holds an H-index of 10. These achievements underscore his consistent contribution to advancing pharmacological and oncological sciences at an international level.

Research Interests

Dr. Coma’s primary research interests include pharmacology, anticancer drug mechanisms, chemotherapy optimization, combination therapies, and experimental cancer models, with a particular emphasis on pancreatic cancer treatment strategies.

Awards, Recognition, and Achievements

Through his scholarly publications, citation impact, and leadership role at a leading medical faculty, Dr. Coma has earned recognition within the scientific community for his dedication to high-quality, impactful research. His work continues to influence ongoing studies in cancer pharmacology and therapeutic innovation.

Benefits of Attending

Attendees will gain valuable insights into emerging pharmacological strategies for cancer treatment, learn about innovative drug combinations in pancreatic oncology, and engage with evidence-based research that supports future clinical applications. The conference also provides a unique opportunity to network with global experts, exchange interdisciplinary ideas, and stay informed about advancements shaping the future of pathology and cancer research.

To explore more about this global scientific platform, visit the official conference website at pathology.utilitarianconferences.com and learn about the upcoming 16th Emirates Pathology, Digital Pathology, and Cancer Conference & Exhibition at pathology.utilitarianconferences.com/16epucg2026. Researchers are encouraged to contribute their work via abstract submission at pathology.utilitarianconferences.com/submit-abstract.

To know more about Dr. Matus Coma, visit:
https://pathology.utilitarianconferences.com/speaker/dr-matus-coma

Register Now:
https://pathology.utilitarianconferences.com/registration

Conclusion

Dr. Matus Coma’s research exemplifies scientific rigor, innovation, and clinical relevance. His participation adds significant value to the conference, offering attendees an opportunity to engage with cutting-edge pharmacological research that addresses real-world challenges in cancer treatment. His work continues to inspire progress in oncology and reinforces the importance of collaborative scientific exchange.



#PathologyConference #CancerResearch #Pharmacology #PancreaticCancer #OncologyResearch #MedicalScience #CancerTherapeutics #DrugDiscovery #TranslationalResearch #ClinicalOncology #ScientificExcellence #GlobalHealthcare #ResearchInnovation #MedicalFaculty #PathologySummit #CancerPharmacology #AcademicResearch #BiomedicalScience #HealthcareConference #DigitalPathology #EvidenceBasedMedicine #ResearchLeadership #ScientificCollaboration #CancerTreatment #MedicalEducation

Comments

Post a Comment

Popular posts from this blog

How Digital Pathology is Accelerating Research and Drug Development

Image
Introduction The field of pathology has undergone a significant transformation with the advent of digital pathology. Traditionally, pathologists relied on glass slides and microscopes to analyze tissue samples. However, digital pathology leverages high-resolution imaging, artificial intelligence (AI), and cloud computing to enhance diagnostic accuracy and efficiency. This technological shift has had a profound impact on research and drug development, accelerating the process of discovering new treatments and improving patient outcomes. Benefits of Digital Pathology Digital pathology offers numerous benefits across diagnostics, research, and drug development. Here are some of the key advantages: 1. Enhanced Efficiency and Productivity Eliminates the need for physical slide handling, reducing time spent on logistics. Enables pathologists to analyze images faster with AI-assisted tools. Reduces turnaround time for diagnoses and research studies. 2. Improved Accuracy ...
Read more

Join Us at the 15th Emirates Pathology, Digital Pathology & Cancer Conference – Dubai & Virtual | September 02–04, 2025

Image
 We are delighted to invite you to participate in the  CME/CPD accredited 15th Emirates Pathology, Digital Pathology & Cancer Conference , taking place from  September 02–04, 2025 , at  Novotel Al Barsha, Dubai, UAE , with both  in-person and virtual  participation options. Whether you are a  Speaker, Listener, Exhibitor, or Poster Presenter , this conference offers a global platform to share insights, present your research, and network with leading experts in the field of pathology and cancer research. 🔗  Conference Website:   https://pathology.utilitarianconferences.com/ 📢 Call for Abstracts, Presentations, Case Studies, and Research Papers We are now accepting submissions! Share your work in one of our diverse scientific tracks: Track 1:  Pathology Track 2:  Digital Pathology Track 3:  Cancer Track 4:  Breast Pathology Track 5:  Computational Pathology Track 6:  Pathology with Technology Track 7:  D...
Read more

How AI Is Revolutionizing Pathology: A Glimpse Into the Future of Diagnosis

  In the past decade, artificial intelligence (AI) has transitioned from a buzzword to a transformative force across industries—and pathology is no exception. Traditionally known for its microscope-laden labs and expert-driven slide interpretations, pathology is undergoing a profound shift as AI technologies become integrated into diagnostic workflows. But what exactly does this transformation look like? And what does the future hold for pathologists, patients, and healthcare as a whole? The Traditional Pathology Workflow—And Its Limitations Pathologists play a crucial role in diagnosing diseases, especially cancer. They analyze tissue samples under a microscope, looking for cellular abnormalities that can confirm or rule out disease. While this work is foundational to patient care, it’s also highly complex, time-consuming, and, at times, subjective. Challenges in the traditional workflow include: High workload and burnout among pathologists Variability in diagnoses ...
Read more